by Truveta staff | Mar 20, 2025 | Data
Why autoimmune research needs better real-world data Biologics like Humira, Enbrel, and Rinvoq have transformed autoimmune treatment, revolutionizing treatment for patients with chronic inflammatory infections. However, the traditional methods of studying these...
by Truveta staff | Aug 19, 2024 | News
Truveta was included in GeekWire’s latest list recognizing the top 200 startups in the Pacific Northwest. With this update of the GeekWire 200, Truveta moved up 14 spots to #38 as the highest-ranking healthcare startup on the list. The company was also included in the...
by Truveta staff | Aug 15, 2024 | Data
Psoriasis is more than just a skin condition – it’s a chronic, systemic disease that affects over 8 million people in the United States, profoundly impacting their quality of life. As a complex, immune-mediated disease, psoriasis presents a variety of challenges to...
by Truveta staff | Jun 14, 2024 | Data
One in every four US households has someone living with migraine. More than a severe headache, migraine is a complex neurological disorder impacting 39 million Americans with more than $36B lost each year in medical expenses and lost productivity. Despite its...
by Truveta staff | Mar 12, 2024 | Data
Stories from women whose endometriosis pain has been dismissed are devastatingly common. A typical woman in the United States will wait 10 years after her symptoms first appear to receive an endometriosis diagnosis. This delay is rooted in a pervasive lack of...
